Insys Therapeutics, Inc. Stock Split Ratio
Insys Therapeutics, Inc. had Stock Split Ratio of 200.00% as of 2015-05-26, per its 10-Q filed 2016-05-05.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2018-03-12
- 2015-05-26: Stockholders' Equity Note, Stock Split, Conversion Ratio 200.00%.
- 2015-05-05: Stockholders' Equity Note, Stock Split, Conversion Ratio 200.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 200.00%.
- 2014-02-26: Stockholders' Equity Note, Stock Split, Conversion Ratio 150.00%.
- 2009-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 150000000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|
| 2015-05-26 | 200.00% 10-Q · filed 2016-05-05 | ||
| 2015-05-05 | 200.00% 10-K · filed 2016-02-29 | 200.00% 10-K · filed 2018-03-12 | |
| 2014-02-26 | 150.00% 10-K · filed 2018-03-12 | ||
| 2009-06-30 | 150000000.00% 10-K · filed 2014-03-05 |